X

Trial Profile

Effects of testosterone [Androgel] replacement on atherosclerosis progression in older men with low testosterone levels.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 03 Nov 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Testosterone (Primary)
Indications Hypogonadism
Focus Therapeutic Use
Acronyms TEAAM

Most Recent Events

04 Apr 2017 Results from 2 randomized trials (TAP and TEAAM) presented at The 99th Annual Meeting of the Endocrine Society
19 Dec 2016 Results of two studies (TAP and TEAAM) published in the Journal of Clinical Endocrinology and Metabolism
19 Dec 2016 Status changed from active, no longer recruiting to completed according to results published in the Journal of Clinical Endocrinology and Metabolism.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com